A Study of GANFORT UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting

Trial Profile

A Study of GANFORT UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Dec 2015

At a glance

  • Drugs Bimatoprost/timolol (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 06 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 23 Nov 2014 Planned End Date changed from 1 Apr 2015 to 1 Nov 2014 as reported by ClinicalTrials.gov
    • 23 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top